Guardant Well being, Inc. (NASDAQ:GH – Get Score) traded up 3.2% on Monday after Financial institution of America raised their worth goal on the inventory from $65.00 to $70.00. The inventory traded as excessive as $31.51 and final traded at $31.03. 63,849 shares traded fingers throughout mid-day buying and selling, a decline of 95% from the common session quantity of 1,222,021 shares. The inventory had beforehand closed at $30.06.
A variety of different analysis companies have additionally just lately commented on GH. Citigroup lowered their goal worth on Guardant Well being from $80.00 to $60.00 in a analysis be aware on Friday. Cowen lowered their goal worth on Guardant Well being from $110.00 to $83.00 in a analysis be aware on Friday, November 4th. Cowen lowered their goal worth on Guardant Well being from $83.00 to $70.00 in a analysis be aware on Friday. Craig Hallum assumed protection on Guardant Well being in a analysis be aware on Wednesday, October nineteenth. They issued a “purchase” ranking and a $88.00 goal worth for the corporate. Lastly, Stephens lowered their goal worth on Guardant Well being from $99.00 to $90.00 and set an “obese” ranking for the corporate in a analysis be aware on Monday, November seventh. One analysis analyst has rated the inventory with a maintain ranking and fourteen have assigned a purchase ranking to the corporate’s inventory. In response to MarketBeat, the inventory presently has a consensus ranking of “Reasonable Purchase” and a consensus worth goal of $93.59.
Insiders Place Their Bets
In different Guardant Well being information, insider Kumud Kalia offered 3,125 shares of Guardant Well being inventory in a transaction on Tuesday, November fifteenth. The inventory was offered at a median worth of $51.87, for a complete worth of $162,093.75. Following the completion of the sale, the insider now owns 20,135 shares of the corporate’s inventory, valued at roughly $1,044,402.45. The transaction was disclosed in a submitting with the SEC, which might be accessed by way of the SEC web site. Company insiders personal 5.90% of the corporate’s inventory.
Hedge Funds Weigh In On Guardant Well being
A variety of institutional traders and hedge funds have just lately modified their holdings of GH. Capital Worldwide Traders boosted its stake in shares of Guardant Well being by 71.0% within the 1st quarter. Capital Worldwide Traders now owns 5,081,624 shares of the corporate’s inventory price $336,607,000 after shopping for an extra 2,110,240 shares over the past quarter. Steadfast Capital Administration LP bought a brand new place in shares of Guardant Well being within the 1st quarter price $67,202,000. Pictet Asset Administration SA boosted its stake in shares of Guardant Well being by 206.7% within the 2nd quarter. Pictet Asset Administration SA now owns 1,034,652 shares of the corporate’s inventory price $41,738,000 after shopping for an extra 697,281 shares over the past quarter. ARK Funding Administration LLC bought a brand new place in shares of Guardant Well being within the third quarter price $29,182,000. Lastly, RA Capital Administration L.P. bought a brand new place in shares of Guardant Well being within the 1st quarter price $31,555,000. 89.36% of the inventory is at the moment owned by hedge funds and different institutional traders.
Guardant Well being Buying and selling Up 4.6 %
The inventory has a market capitalization of $3.22 billion, a PE ratio of -5.07 and a beta of 0.64. The corporate has a present ratio of 6.46, a fast ratio of 6.10 and a debt-to-equity ratio of 6.82. The inventory has a 50 day shifting common worth of $47.78 and a 200-day shifting common worth of $48.58.
Guardant Well being (NASDAQ:GH – Get Score) final launched its earnings outcomes on Thursday, November third. The corporate reported ($1.58) earnings per share for the quarter, lacking the consensus estimate of ($1.27) by ($0.31). The corporate had income of $117.40 million for the quarter, in comparison with analysts’ expectations of $118.18 million. Guardant Well being had a adverse internet margin of 140.58% and a adverse return on fairness of 145.58%. Promote-side analysts anticipate that Guardant Well being, Inc. will put up -6.39 earnings per share for the present yr.
Guardant Well being Firm Profile
(Get Score)
Guardant Well being, Inc, a precision oncology firm, supplies blood checks, information units, and analytics in america and internationally. The corporate affords Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based checks for superior stage most cancers; and GuardantINFORM, an in-silico analysis platform that comprise a clinical-genomic liquid biopsy dataset of superior most cancers sufferers.
Featured Articles
This on the spot information alert was generated by narrative science expertise and monetary information from MarketBeat with a view to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial workforce previous to publication. Please ship any questions or feedback about this story to contact@marketbeat.com.
Earlier than you take into account Guardant Well being, you will wish to hear this.
MarketBeat retains monitor of Wall Avenue’s top-rated and greatest performing analysis analysts and the shares they suggest to their shoppers every day. MarketBeat has recognized the 5 shares that high analysts are quietly whispering to their shoppers to purchase now earlier than the broader market catches on… and Guardant Well being wasn’t on the listing.
Whereas Guardant Well being at the moment has a “Reasonable Purchase” ranking amongst analysts, top-rated analysts consider these 5 shares are higher buys.
View The 5 Shares Right here
